Eye health after forty is largely the story of four conditions — cataract, glaucoma, diabetic eye disease and age-related macular degeneration — and of the strange fact that most vision loss from all four is preventable or slowable if caught, while all four begin silently. That is why the recurring advice in this hub is an unglamorous one: the periodic dilated eye exam, which finds every one of them years before symptoms would.
This hub is also home to the supplement industry's one genuine trophy. The AREDS trials — run by the U.S. National Eye Institute across thousands of patients and two decades — established that a specific antioxidant-and-zinc formula slows progression in people who already have intermediate macular degeneration. It is real, it is specific, and it is narrow: the same trials showed the formula does nothing to prevent the disease in healthy eyes, and nothing for cataract. Nearly every "vision support" product on the market borrows AREDS's glow while quietly departing from its formula, its doses, or its population — a pattern our ingredient and product pages measure precisely.
The rest of the hub covers the everyday questions — floaters and when they're an emergency, dry and tired eyes, screens and children's sight — with the same rule as everywhere on this site: mechanisms first, evidence graded, and the exam that actually protects sight recommended without embarrassment.